Modafinil Enantiomer Analysis? [Regulatives / Guidelines]

posted by hari emmadi – India, 2016-08-22 08:30 (2775 d 12:46 ago) – Posting: # 16561
Views: 1,863

Dear All,



We are planning to conduct bioequivalence study of Modafinil 100 mg tablets for Australia submission. Modafinil is a racemic compound and in SMPC it has been mentioned that “the enantiomers have different pharmacokinetics where the elimination t1/2 of the R-isomer is three times that of the S-isomer in adult humans”. However they are pharmacologically equipotent.

As per applicable guideline, whether we need to establish bioequivalence on each enantiomer or racemic will suffice the regulatory requirement.

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
95 visitors (0 registered, 95 guests [including 8 identified bots]).
Forum time: 20:17 CET (Europe/Vienna)

Nothing shows a lack of mathematical education more
than an overly precise calculation.    Carl Friedrich Gauß

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5